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Abstract
Difference-in-differences (diff-in-diff) is a study design that compares outcomes of
two groups (treated and comparison) at two time points (pre- and post-treatment)
and is widely used in evaluating new policy implementations. For instance, diff-
in-diff has been used to estimate the effect that increasing minimum wage has on
employment rates and to assess the Affordable Care Act’s effect on health outcomes.
Although diff-in-diff appears simple, potential pitfalls lurk. In this paper, we discuss
one such complication: time-varying confounding. We provide rigorous definitions
for confounders in diff-in-diff studies and explore regression strategies to adjust for
confounding. In simulations, we show how and when regression adjustment can ame-
liorate confounding for both time-invariant and time-varying covariates. We compare
our regression approach to those models commonly fit in applied literature, which
often fail to address the time-varying nature of confounding in diff-in-diff.
Keywords: difference-in-differences, time-varying confounding, parallel trends, regression
adjustment, matching
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1 Introduction
Difference-in-differences (diff-in-diff) studies contribute to policy discourse by evaluating
efficacy of newly enacted policies and programs. For example, diff-in-diff has been used to
estimate the effects of raising minimum wage on employment rates (Card & Krueger 1993)
as well as the effects of new medical cannabis laws on opioid prescriptions (Bradford et al.
2018). Diff-in-diff’s most attractive features are its simplicity and wide applicability; anyone
with a rudimentary understanding of experimental design and regression can implement it.
To carry out diff-in-diff, we just require observations from a treated group and an untreated
(comparison) group both before and after the intervention is enacted.
Recent studies have leveraged diff-in-diff to estimate the effects of expanded Medicaid
eligibility through the Affordable Care Act (ACA) in the United States. Following the
ACA’s passage and subsequent Supreme Court ruling (National Federation of Independent
Business v. Sebelius 2011), each state chose whether to expand its threshold for Medicaid
eligibility. Some did and others did not, creating groups of treated and comparison states
and enabling natural experiements using diff-in-diff (Antonisse et al. 2018). For example,
one of these (Blavin 2016) showed that hospitals in states that expanded Medicaid saw
lower uncompensated care costs. Another showed that people in Medicaid expansion states
experienced improved access to and affordability of health care (Kobayashi et al. 2019).
These studies have informed ongoing policy debates about the future of the ACA and state
Medicaid waivers.
As in any causal inference prodcedure, diff-in-diff relies on strong and unverifiable as-
sumptions. The key assumption for diff-in-diff is that the outcomes of the treated and
comparison groups would have evolved similarly in the absence of treatment. Notably, diff-
in-diff does not require the treated and comparison groups to be balanced on covariates,
unlike in cross-sectional studies. Thus, a covariate that differs by treatment group and is
associated with the outcome is not necessarily a confounder in diff-in-diff. Only covariates
that differ by treatment group and are associated with outcome trends are confounders in
diff-in-diff as these are the ones that violate our causal assumptions.
Despite the lurking pitfalls, many diff-in-diff studies appear to be run on autopilot: plot
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the data, test for parallel outcome trends before the intervention, and fit a regression that
includes an interaction between time with treatment, perhaps with some adjustment for
covariates. Rarely are the mechanisms of confounding discussed or the model specifications
interrogated.
In this paper, we discuss the unique features of diff-in-diff that run afoul of our un-
derstanding of confounding and regression adjustment imported from other settings. Con-
founders are fundamentally different in diff-in-diff. We show how covariates, both time-
invariant and time-varying, affect the causal assumptions and inform analysis choices. Us-
ing simulations, we demonstrate how to adjust for these confounders and compare re-
gression to matching techniques. We offer applied researchers advice and strategies to
estimate unbiased causal effects using diff-in-diff by combining substance matter expertise
with thoughtful modeling.
2 Parallel Trends
In cross-sectional studies, the definition of a confounder comes from the assumption that
potential outcomes are independent of treatment. Colloquially, we say that a confounder
is a covariate associated with both treatment and outcome, and we must condition on all
confounders for independence between treatment and outcomes to hold. VanderWeele &
Shpitser (2013) noted the lack of rigor in the definition of a confounder and provided several
formal definitions. In this spirit, we examine what confounding means in diff-in-diff.
Diff-in-diff studies focus on the average effect of treatment on the treated (ATT) at
post-intervention point t∗ ≥ T0, where
ATT (t∗) = E
{
Y 1(t∗)− Y 0(t∗) | A = 1} , ]. (1)
T0 is the time at which the policy is implemented, A = 1 represents the treated group, and
Y (t) is a continuous outcome recorded at time t with Y a(t) denoting its counterfactuals.
Since Eq. (1) contains counterfactuals we never observe (that is, Y 0(t∗) for the treated
group), we rely on assumptions to identify this quantity using observables. To start, we
assume no anticipation effects of treatment so that the pre-treatment outcomes are not
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affected by any treatment received in the future. From this, it follows that the observed
outcomes and the potential outcomes are the same at pre-treatment times, Y (t) = Y 0(t) =
Y 1(t) for t < T0. We also assume that the post-treatment potential outcome corresponds
to actual treatment received, Y (t) = Y 0(t)(1− A) + Y 1(t)A.
Identification relies on the parallel trends assumption, which we formally define in the
simplest possible setting of two time points, one pre- and one post-treatment. Although
some literature on diff-in-diff separates the key assumption into two components, parallel
trends and common shocks (Angrist & Pischke 2008, Chapter 5.2), we use the term “parallel
trends” to refer to the combination of the two and write it formally as
E
{
Y 0(1)− Y 0(0) | A = 0} = E {Y 0(1)− Y 0(0) | A = 1} . (2)
The assumption in Eq. (2) is based on changes in potential outcomes. That is, we
assume the average change in the untreated potential outcomes from pre- to post-treatment
is the same for the treated and comparison groups. Since the untreated potential outcome
in the post-treatment period (Y 0(1)) is unobservable for the treated group (A = 1), this
assumption is untestable.
This definition of parallel trends with two time points is nearly universal in the diff-
in-diff literature (Abadie 2005). However, data in many applications contain more than
two time points, so we extend the assumption accordingly. Let T be the total number of
time points and T0 ≤ T be the first post-treatment time point. In the strictest version of
parallel trends, every pair of time points satisfies Eq. (2). That is,
E
{
Y 0(t∗)− Y 0(t′) | A = 0} = E {Y 0(t∗)− Y 0(t′) | A = 1} , (3)
for t∗ 6= t′. While it is possible to relax this assumption, this is the version researchers likely
have in mind when testing for parallel trends in the pre-intervention periods, contending
that evidence of parallel trends before treatment strengthens the plausibility of parallel
trends over the whole study period.
Given these assumptions and the parallel trends assumption in Eq. (3), we can re-write
the ATT in a form that involves only observable quantities (Lechner 2011, Section 3.2.2),
as follows:
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ATT (t∗) = [E {Y (t∗) | A = 1} − E {Y (t′) | A = 1}]−
[E {Y (t∗) | A = 0} − E {Y (t′) | A = 0}] ,
with t′ < T0. To estimate the ATT, we can now select from a variety of estimators, ranging
from a simple nonparametric estimator using sample means to more sophiscated estimators
such as those using inverse probability weighting (Stuart et al. 2014).
2.1 Regression Models for Difference-in-Differences
We start by specifying a simple model for the untreated potential outcomes conditional on
a covariate. Following convention in diff-in-diff literature (O’Neill et al. 2016), we write a
linear model for the expected untreated potential outcomes of the ith unit
E
[
Y 0i (t)|A = ai, X = xit
]
= α0 + α1ai + ζt + λtxit , (4)
where ζt are time fixed effects and ai is an indicator of the treated group (i.e, ai = 1 if
the ith unit is in the treated group and ai = 0 otherwise). We allow the covariate xit to
vary across units i and (possibly) across time t. Let α0 be the intercept, α1 the constant
difference between treated and comparison groups, and λt the time-varying effect of the
covariate on the outcome. Denote the group-time mean of the covariate E[Xit|A = a] by
τa,t.
We pause here to note that there are a handful of other data-generating models pro-
posed in different settings. For example, Bai (2009) proposes an interactive fixed effects
model. The generalized synthetic control method extends interactive fixed effects by adding
heterogeneous treatment effects (Xu 2017). All this indicates that there are many ways to
set up this problem. We chose the above because it is straightforward and familiar to most
readers. However, investigating the effect of confounding under different models may pose
unique challenges.
Assuming the data-generating model from Eq. (4), we can identify situations in which
the covariate is a confounder for our diff-in-diff estimator, meaning that the presence of
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the covariate threatens the parallel trends assumption when not properly accounted for.
In the following sections, we show that, for a time-invariant covariate, the parallel trends
assumption will be violated (and X will be a confounder) when two conditions hold: (1)
the mean of X varies by treatment group and (2) the relationship of X to the outcome
varies over time. For a time-varying covariate, X will be a confounder if its distribution
evolves differentially between the treated and comparison groups (regardless of whether the
effect on the outcome is constant).
2.2 Parallel Trends in the Presence of Covariates
We demonstrate the conditions described above in the simple case of only two time points,
t ∈ {0, 1}. We begin with expressions for the mean change in untreated potential outcomes
from pre- to post-treatment in each group, by plugging Eq. (4) into the parallel trends
assumption of Eq. (2). In the treated group, the change over time is
E
[
Y 0(1)− Y 0(0) | A = 1] = (α0 + α1 + ζ1 + λ1τ1,1)− (α0 + α1 + ζ0 + λ0τ1,0)
= ζ1 − ζ0 + λ1τ1,1 − λ0τ1,0 ,
and for the comparison group, it is
E
[
Y 0(1)− Y 0(0) | A = 0] = (α0 + ζ1 + λ1τ0,1)− (α0 + ζ0 + λ0τ0,0)
= ζ1 − ζ0 + λ1τ0,1 − λ0τ0,0 .
Subtracting the two, we get the differential change in untreated potential outcomes between
treated and comparison groups:
(ζ1 − ζ0 + λ1τ1,1 − λ0τ1,0)− (ζ1 − ζ0 + λ1τ0,1 − λ0τ0,0) =
λ1 (τ1,1 − τ0,1)− λ0 (τ1,0 − τ0,0) . (5)
The parallel trends assumption in Eq. (2) constrains this difference to be 0. Given the
data-generating model in Eq. (4), we can put conditions on the means and coefficients of
the covariates (λ’s and τ ’s) that will ensure the parallel trends assumption holds. Then we
define confounders as variables that fail to satisfy those conditions.
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First, consider a covariate that is constant over time (e.g., birth year). Writing the mean
of X in the treated group τ1,0 = τ1,1 = τ1 and in the comparison group as τ0,0 = τ0,1 = τ0,
the differential change in Eq. (5) simplifies to
λ1(τ1 − τ0)− λ0(τ1 − τ0) = (λ1 − λ0)(τ1 − τ0) . (6)
Whenever τ0 6= τ1, Eq. (6) will be zero if and only if λ0 = λ1. Conversely, if λ0 6= λ1,
Eq. (6) will be zero if and only if τ0 = τ1. This implies that for a time-invariant covariate,
and absent the effects of other factors, parallel trends holds if either: (1) the means of the
covariate are the same across groups or (2) the effect of the covariate on the outcome is
the same across time points.
Next, consider a covariate that varies over time (e.g., blood pressure measured at each
t). Eq. (5) will be zero — satisfying parallel trends — if two conditions are met: the
relationship of the covariate to the outcome is constant (λ0 = λ1) and the difference in
the mean of the covariate between groups is equal (τ1,1 − τ0,1 = τ1,0 − τ0,0). From this,
we can see a time-varying covariate is a confounder if its relationship to the outcome is
time-varying or the covariate evolves differently in the treated and comparison groups.
Putting this all together, a confounder in diff-in-diff is a variable with a time-varying
effect on the outcome or a time-varying difference between groups. Compare this to the
colloquial defintion of a confounder in cross-sectional settings: a variable associated with
both treatment and outcome. In diff-in-diff, a confounder always has some time-varying
effect. Either the relationship of the variable to the outcome changes over time or the
variable evolves differently between the groups over time.
Next, we consider adjusting for these types of confounding variables in the data-
generating model of Eq. (4) using a linear regression model in which we assume the
confounder is measured. An effective adjustment strategy must remove either covariate
differences between groups or account for their time-varying effects on the outcome. In
addition to regression adjustment, one might also consider matching and inverse propen-
sity score techniques (Ryan et al. 2015, Stuart et al. 2014). We discuss matching briefly in
Section 3.3 and compare it to regression in Section 5.
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3 Adjusting for Confounders
To facilitate a regression approach for confounder adjustment, we first connect the un-
treated potential outcomes in Eq. (4) to the treated potential outcomes and then to the
observed outcomes. First, we assume a constant, additive effect of treatment, relating the
treated and untreated potential outcomes for post-treatment times t ≥ T0 as
Y 1i (t) = Y
0
i (t) + γ .
Then we write the expected observed outcomes as
E [Yi(t) | A = ai, X = xit] = α0 + ζt + α1ai + λtxit + γptai , (7)
where pt is an indicator of being in a post-treatment time point. We use a linear regression
model to estimate the diff-in-diff parameter γ.
3.1 Adjusting for Time-Invariant Confounders
Whenever X is a time-invariant baseline confounder and we use a linear regression model
to estimate the ATT, simply including a term for the main effect of X (in addition to
the usual a group effect, a post-treatment indicator pt, and their interaction) will not
eliminate bias. Nevertheless, methods in the applied literature consistently adjust for main
effects of observed covariates (McWilliams et al. 2014, Rosenthal et al. 2016, Desai et al.
2016, Roberts et al. 2018). Likely these choices are made out of habit rathen than with
consideration to the unique assumptions of diff-in-diff. While inclusion of covariates might
not harm estimates of the ATT, it might not be necessary.
We demonstrate that adjusting only for main effects is ineffective in correctly non-
parallel trends using a toy example with two time points. Suppose we have a time-invariant
covariate xi with different means in the two groups, E[X | A = 0] = τ0 = 0 and E[X | A =
1] = τ1 = 1, and a time-varying effect with λ0 = 0 and λ1 = 1. Because we are interested in
the covariate’s effect on parallel trends — which involve only the untreated counterfactuals
— we include no treatment effect. This means the observed outcomes and the untreated
potential outcomes are equal, so we can illustrate our points in observed data. Outcomes
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are generated from Eq. (4) with α0 = 1, α1 = −1, ζ0 = 1, and ζ1 = 2. The covariate is
a confounder because its relationship to the outcome varies over time (λ0 6= λ1) and its
means in the treated and comparison groups differ (τ0 6= τ1).
In Panel (a) of Figure 1, we plot the mean outcomes by group and time. The non-parallel
outcome evolution in the two groups is apparent. Without accounting for the confounding,
we would incorrectly attribute differential outcome changes to the treatment. Panel (b)
shows residuals from a simple linear regression with only a time effect. This model does
not include the covariate X, so we would not expect the model to correct for deviations
from parallel trends. We see that the residuals, like the outcomes, are not parallel. In
Panel (c), we add a main effect for the covariate X to the model. However, the residuals
for the two groups still diverge. In Panel (d), we add an interaction between X and time.
Only in this model do we properly account for the time-varying nature of the confounder
and obtain an unbiased result (recall the true treatment effect is zero here).
This illustrates just one data-generating scenario and a few simple models. In the simul-
tations of Section 4, we provide a more comprehensive look at how covariate adjustment
through regression and matching can address confounding in diff-in-diff.
3.2 Adjusting for Time-Varying Confounders
Like time-invariant confounders, time-varying confounders invalidate parallel trends and
introduce bias into our estimate of the ATT. If we were to adjust for time-varying con-
founding either by including the main effect or its interaction with time in a regression,
we risk conditioning on post-treatment covariates that may be affected by treatment. As
Rosenbaum (1984) notes for observational data, at best adjusting for post-treatment co-
variates provides no benefit; at worst, it may introduce additional bias. This is because
the time-varying covariate can act as both a confounder and as a mediator. As such, when
trying to recover the ATT via regression, the usual interaction parameter may not be an
unbiased estimate of the ATT.
To see why this is the case, imagine three different scenarios: (a) the time-varying
covariate changes in a way completely unrelated to treatment, (b) the time-varying covari-
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Figure 1: Adjusting for the main effect of a covariate does not correct for diverging trends,
but adjusting for the interaction with time does in a simulated example where untreated
potential outcomes depend on a time-invariant covariate with a time-varying effect. Panel
(a) shows untreated potential outcomes. Panels (b)-(d) show residuals from linear models.
The function lm fits a linear model with outcome y. In panel (b), the only predictor is
time. In panel (c), the predictors are the main effects of time and the covariate. In panel
(d), the predictors are time, the covariate, and an interaction between the two.
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ate changes in a way wholly determined by treatment, and (c) the time-varying covariate
changes in a way determined by a combination of treatment and other factors. Whenever
(b) or (c) is true and the time-varying covariate is a cause of the outcome, the ATT is a
combination of the direct effect of treatment and the indirect effect of treatment via the
covariate. As a result the regression parameter on the interaction between treatment and
the post-treatment indicator may not equal the ATT, even adjusted for the time-varying
covariate. However, if we fail to account for the covariate, we face parallel trends violations.
For a more detailed explanation, please see Appendix Section A.
In the causal inference literature, g-methods were specifically designed to deal with
time-varying confounding (Hernan & Robins 2019). A handful of papers incorporate these
techniques into the diff-in-diff framework such as inverse probability weighting (Stuart et al.
2014, Han et al. 2017). However, only one employs inverse probability weighting to account
for changes in covariate distributions across time (Stuart et al. 2014). In that paper, the
authors consider a two time point/two group setting and define a new variable with four
levels (treatment group in the pre-treatment period, treatment group in the post-treatment
period, etc.). However, this methodology was only demonstrated on data with two time
points and it should be noted that the target estimand changes from the classic ATT to an
average treatment effect defined in the treatment group at the first time point. Nevertheless,
it remains one of the only diff-in-diff papers to directly address the issue of time-varying
confounders. In this paper, we use simulations to demonstrate that the estimate of the
ATT is biased when time-varying covariates are affected by treatment, whether we adjust
for the time-varying covariate or not (see Scenario 6 of Section 4.2).
3.3 What about Matching?
Matching aims to reduce confounding bias by selecting units from the treated and com-
parison groups that have similar observable characteristics. This eliminates imbalances
between the groups, which is a key ingredient in confounding. When matching, we can
match observations on pre-treatment outcomes, pre-treatment covariates, or some combi-
nation.
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Matching on pre-treatment outcomes allows us to use an alternative assumption to
identify the target parameter. This assumption — independence between potential out-
comes and treatment assignment conditional on past outcomes — is the basis of lagged
dependent variables regression and synthetic control methods (Lechner 2011, O’Neill et al.
2016, Ding & Li 2019). However, matching on pre-treatment outcomes in diff-in-diff can
yield unwanted results. In some settings, it reduces bias (Stuart et al. 2014, Ryan et al.
2015), while in others, matching induces regression to the mean and creates bias (O’Neill
et al. 2016, Daw & Hatfield 2018).
Matching only on time-invariant pre-treatment covariates is attractive because it re-
moves differences in the covariate distribution between the groups. With time-varying
covariates, the picture is more complicated. Matching on time-varying pre-treatment co-
variates is subject to the same threat of bias due to regression to the mean as matching
on pre-treatment outcomes. Moreover, if confounding arises because of differential evo-
lution of the covariate in the two groups, matching only on pre-treatment values will be
insufficient to address the confounding. Thus, we may wish to match on both pre- and
post-treatment values of a time-varying covariate. In this case, we must also be wary of
the dangers of matching on post-treatment variables that may be affected by treatment
(Rosenbaum 1984). Clearly, choosing the right matching variables is the key to effective
matching. A good overview on the current state of matching for diff-in-diff is provided by
Lindner & McConnell (2018).
Returning to the demonstration of parallel trends in Figure 1, matching on the pre-
treatment covariate also serves to fix diverging trends. Recall that the data-generating
model was a time-invariant covariate with a time-varying effect on the outcome. Elimi-
nating the difference between the covariate means in the treated and comparison group
via matching is sufficient to address confounding. If the confounding had arisen due to a
time-varying covariate, the strategy may not suffice.
Both matching and regression adjustment have potential pitfalls. In addition to the
possible regression to the mean problem mentioned above, we can mistakenly match on
noise or on a set of covariates that is insufficient to alleviate bias in our causal effect.
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Furthermore, matching choices are largely ad hoc and can depend on the data structure
itself. For example, it’s much more straightforward to match in panel data than in repeated
cross-sections. Regression adjustment is not without its limitations as well. We can overfit
our model, for one. We can also choose the wrong covariates to include or mispecify
the functional form of the model. Deciding whether to address diverging trends through
matching or regression or both must be done carefully. For example, say we are missing a
key covariate that we suspect drives divergent trends, we cannot address the bias through
regression adjustment and could instead consider matching on pre-treatment outcomes as
a proxy for the missing covariate. On the other hand, if we have repeated cross-sectional
data and it’s not clear how to match effectively, we can choose regression adjustment.
4 Simulations
We use simulation to compare regression adjustment and matching strategies in diff-in-
diff. In each simulation scenario, we generate 400 datasets of n = 800 units observed at
T = 10 time points. The first 5 time points are pre-treatment times, and the last 5 are
post-treatment. Each unit is assigned to the treatment group with probability 0.5. To
each simulated data set, we apply regression and matching techniques that reflect current
practice in the applied literature and compare the bias of the resulting treatment effects.
We simulate data and analyze it using the R environment (R version 3.6.1 (R Core Team
2019)). We fit regression models using the lm function and estimate post-hoc cluster-robust
standard errors using the cluster.vcov function in the multiwayvcov package (Graham
et al. 2016). To match, we use the MatchIt package (Ho et al. 2011). We present averages,
across simulated data sets, of the percent bias and standard error of the estimated treatment
effect.
Below, we describe the specifics of our data-generating and analysis models, first for
scenarios with time-invariant covariates and then for scenarios with time-varying covariates.
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Scenario Data-Generating Model
1: Time-invariant
covariate effect
Xi
ind∼ N (m(ai), v(ai))
Yi(t)
ind∼ N (1 + ai + aipt + ui + xi + f(t), 1)
2: Time-varying
covariate effect
Xi
ind∼ N (m(ai), v(ai))
Yi(t)
ind∼ N (1 + ai + aipt + ui + xi + f(t) + g(xi, t), 1)
3: Treatment-
independent
covariate
Xi
iid∼ N (1, 1)
Yi(t)
ind∼ N (1 + ai + aipt + ui + xi + f(t) + g(xi, t), 1)
Table 1: Data-generating models with a time-invariant covariate, xi. Yi(t): outcome for
ith subject at time t. ai: group indicator. ui: random intercept. pt: indicator of post-
treatment time point. The treatment assignment for all scenarios is ai
iid∼ Bernoulli(0.5)
and the unit-level intercepts are all ui
iid∼ N(0, .252). m(ai) = 1.5−0.5ai, f(t) = (t−2.5)2/10,
g(xi, t) = (xi · t)/10, v(ai) = (1.5− 0.5ai)2.
4.1 Time-Invariant Covariate
4.1.1 Data-generating models
Our first set of simulations involves a time-invariant covariate. In Scenario 1, the distribu-
tion of X is different in the treated and control groups, but X has a time-invariant effect on
the outcome Y . Scenario 2 is the same as Scenario 1 but we allow the effect of X on Y to
vary over time. In Scenario 3, the effect of X on the mean of Y is again time-varying, but
the distribution of X is the same in the treated and control groups. Table 1 summarizes
the data-generating processes for these three simulations
We expect that in Scenarios 1 and 3, anlyses that do not adjust for X will be unbiased,
because X does not satisfy the definition of a confounder. In Scenario 1, this is because
X does not have a time-varying effect on Y ; in Scenario 3, this is because the distribution
of X is the same in both groups. In Scenario 2, we expect that only analyses that adjust
appropriately for the time-varying effect of X on Y will yield unbiased results. For all three
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Model Pseudo R code
Simple lm(y ~ a*p + t)
Covariate-Adjusted (CA) lm(y ~ a*p + t + x)
Time-Varying Adjusted (TVA) lm(y ~ a*p + t*x)
Match on pre-treatment outcomes lm(y ~ a*p + t,data=out.match)
Match on pre-treatment first differences lm(y ~ a*p + t,data=out.lag.match)
Match on pre-treatment covariates lm(y ~ a*p + t,data=cov.match)
Table 2: Analysis methods applied to each simulation scenario. The function lm fits a
linear model for outcome y, treatment group indicator a, post-treatment period indicator
p, (factor-coded) time t, and covariate x. The notation p*q yields main effects for p and q
plus their interaction.
scenarios, the ATT equals the regression parameter which was set to 1. We measure bias
with respect to this true ATT.
4.1.2 Analysis approaches
We use both matched and unmatched regression to analyze the simulated data. All regres-
sion models include time fixed effects and indicators for treatment, the post-period, and
their interaction. The simple model includes only those elements, ignoring the covariate en-
tirely. The covariate adjusted (CA) model adjusts for the covariate using a constant effect
on the outcome over time. The time-varying adjusted (TVA) model allows the coefficient
on the covariate to vary over time.
Our matching strategies include matching on both outcomes and covariates. We use
nearest-neighbor matching on 1) the vector of pre-treatment outcomes, 2) the vector of
pre-treatment outcome first differences, or 3) pre-treatment covariates. To each matched
dataset, we fit a simple model without covariate adjustment. Table 2 describes the adjust-
ment methods and gives pseudo code for each.
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4.2 Time-Varying Covariate
4.2.1 Data-generating models
The second set of simulations involves a time-varying covariate, with means that may evolve
differently in the treated and comparison groups. The basic setup of these simulations (i.e.,
the number of units, time points, and treatment assignment) is the same as in Scenarios
1 through 3 above. We include three types of covariate evolution. In Scenario 4, the
covariate evolves the same for both the treated group and the comparison group; in Scenario
5, the covariate evolves differently starting from baseline (related to treatment group, not
treatment itself); and in Scenario 6, the covariate evolves the same in the two groups before
treatment but differently after treatment.
For all these scenarios, we have two outcome processes: (a) the covariate has a time-
invariant effect of the outcome and (b) the covariate has a time-varying effect on the
outcome. Each scenario embeds two sub-scenarios, for a total of six data-generating pro-
cesses. The data-generating distributions are summarized in Table 3. For Scenarios 4 and
5, the ATT equals the regression parameter (set to 1) as it did in Scenarios 1 through
3. However, Scenario 6 has a covariate that is changed by treatment, acting in part as a
mediator. Thus, for Scenario 6, the ATTs are 0.85 and 0.87 for outcome processes (a) and
(b), respectively. Work showing these calculations is provided in Appendix Section B. For
all scenarios, we measure bias relative to the true ATT.
4.2.2 Analysis approaches
The analysis methods are the same as in Section 4.1.2 and Table 2, except that for these
scenarios with a time-varying covariate, we match on the vector of pre-treatment covariate
values.
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Scenario Data-Generating Model
4: Parallel
evolution
Xti = x(t−1)i +m1(t) · z
Yi(t)
ind∼ N (1 + ai + aipt + ui + xti + f(t) + g(xi, t), 1)
5: Evolution differs
by group
Xti = x(t−1)i +m2(ai, t) · z
Yi(t)
ind∼ N (1 + ai + aipt + ui + xti + f(t) + g(xi, t), 1)
6: Evolution
diverges in post
Xti = x(t−1)i +m1(t) · z −m3(ai, t)
Yi(t)
ind∼ N (1 + ai + aipt + ui + xti + f(t) + g(xi, t), 1)
Table 3: Data-generating models with time-varying covariates, xti. Yi(t): outcome for
ith subject at time t. ai: group indicator. ui: random intercept. pt: indicator of post-
treatment time point. The treatment assignment for all scenarios is ai
iid∼ Bernoulli(0.5),
the unit-level intercepts are ui
iid∼ N(0, .252), the covariate value at the first time point is
X1i
ind∼ N (1.5− 0.5ai, (1.5− 0.5ai)2), and z iid∼ N(1, 0.12). The functions that govern the
evolution of the covariate are m1(t) = (t − 1)/10, m2(ai, t) = (Iai=1 − Iai=0)(t − 1)/10,
and m3(ai, t) = aiptt/20. Outcome process (a) uses f(t) = (t − 2.5)2/10 and g(xi, t) = 0.
Outcome process (b) uses f(t) = (t− 2.5)2/10 and g(xi, t) = (xi · t)/10.
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Figure 2: Simulation Results for Time-Invariant Covariate. CA = Covariate adjusted; TVA
= Time-varying adjusted.
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4.3 Simulation Results
4.3.1 Time-Invariant Covariate
Figure 2 shows the results of fitting the models in Table 2 to the data generated from
the time-invariant covariate data-generating models in Table 1. In Scenario 1, while X
is associated with treatment, it is not a confounder because the effect does not vary over
time. Thus, the unadjusted analysis (simple model) is unbiased and adjusting for X in the
CA and TVA models does not affect either bias or standard errors. The results from our
matched regressions are similar to those from the unmatched regressions.
In Scenario 2, the time-varying effect of X on Y makes X a confounder and thus requires
covariate adjustment with a time-varying aspect. Adjusting for the main effect of X (CA
model) does not alleviate bias or reduce the estimate’s standard error. Fortunately, we
can address the bias by adjusting for the interaction of X with time (TVA model). Of the
matching strategies, only matching on the covariate effectively eliminates bias.
In Scenario 3, the simple model is already unbiased because X is not a confounder. In
fact, all estimation strategies yield unbiased estimates except matching on pre-treatment
outcomes, which is biased by about 10 percent due to regression to the mean. We see
about 20% lower mean standard error when we adjust for the covariate in the TVA model
compared to the simple model.
4.3.2 Time-Varying Covariate
Figures 3 and 4 show the results of fitting the models in Table 2 to the data generated
using time-varying covariate processes (Table 3). In Scenario 4, there is no confounding
when the effect of X on Y is constant over time, and the mean of X evolves the same
for each group. As a result, each modeling strategy is unbiased. However, when X has
a time-varying effect on Y , X is a confounder and only time-varying adjustment (TVA)
eliminates bias. Matching on the vector of pre-treatment values of X nearly eliminates the
bias.
In Scenario 5, the time-varying covariate evolves differently by group, beginning at
baseline. When the effect of X on the outcome is constant, we can simply adjust for time-
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Figure 3: Simulation Results for Time-Varying Covariate. CA = Covariate adjusted; TVA
= Time-varying adjusted.
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Figure 4: Simulation Results for Time-Varying Covariate. CA = Covariate adjusted; TVA
= Time-varying adjusted.
21
varying X (CA model) to eliminate confounding bias. When the effect of X on Y varies
over time, we must adjust for the interaction of X and time (TVA model). All of the
matching strategies have significant bias.
In Scenario 6, the time-varying covariate evolves differently by group, but only after
the treatment is introduced at t = 6. Recall that in this scenario, the ATT does not simply
equal the regression coefficient on an interaction term. As a result in Scenario 6, we have
significant bias in our estimates and never succeed in recovering the true ATT.
5 Discussion
Diff-in-diff applications and methods have expanded dramatically over the past few decades.
We contribute to this growing literature by examining how observable covariates may vio-
late causal assumptions and comparing regression strategies to adjust for violations. It is
tempting to toss all observed covariates into a regression model, but the form of the model
specification should be tailored to address time-varying confounding.
Our methods and conclusions have several limitations. First, adjusting for confounders
spends degrees of freedom, which may be untenable for sparse data. Second, regression ad-
justment depends on knowing and measuring the confounders as well as the functional form
of their effects on the outcome (or having sufficient data to model it flexibly). Third, our
conclusions only apply to linear models; nonlinear models are more complicated (Karaca-
Mandic et al. 2012).
Done properly, regression adjustment can address bias caused by diverging trends. Fur-
ther, even in the absence of confounding, adjusting for covariates can improve efficiency
of the effect estimate (see Scenario 3 of Figure 2). And a correctly specified regression
approach avoids conditioning on pre-treatment outcomes and so is not susceptible to re-
gression to the mean in the same way that some matching methods are (Daw & Hatfield
2018). Lastly, our regression adjustment strategy is agnostic to the structure of the data,
whether panel data versus repeated cross-sections. Our simulations assumed panel data
but our results will hold for repeated cross-sections. Matching on repeated cross-sections is
trickier, since some covariates will necessarily be measured on different subjects at different
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time points, but it is possible (Keele et al. 2019).
For researchers using diff-in-diff in applied work, we recommend several steps for ad-
dressing confounding. First, researchers should clearly specify their model and explain how
the inclusion of covariates and their functional forms support the researcher’s assumptions
and model. This begins with writing out the full model specification and by providing anal-
ysis code in supplementary materials. Each covariate and coefficient should correspond to
a threat to the validity of parallel trends and provide a valid remedy. We also recommend
researchers comprehensively list covariates — both observed and unobserved — that might
cause violations of parallel trends. The list should contain information on whether the
variable is observed, whether the distribution of the covariate is expected to differ in the
treatment and comparison groups, whether the covariate is time-varying, and whether it
has an effect on the outcome. Depending on the application, we can use such a list to
inform analysis choices. For example, if many unobserved covariates are a concern, the
analyst may choose a different estimator (instead of one that relies on diff-in-diff and the
parallel trends assumption). On the other hand, a single time-invariant covariate suggests a
straightforward regression approach. Approaching both measured and unmeasured covari-
ates illuminates the crucial causal assumptions underlying diff-in-diff more so than any test
of parallel pre-treatment outcomes (Bilinski & Hatfield 2018). Other authors have given
similar advice, stressing attention to the reasons for baseline differences between the treated
and comparison groups and how these differences might affect parallel trends (Kahn-Lang
& Lang 2018).
Being thorough in our diff-in-diff studies will strengthen conclusions and help alleviate
concerns on the credibility of parallel trends. We expect diff-in-diff to continue its critical
role in informing policy decisions into the foreseeable future. Going forward, it is crucial
that diff-in-diff methodology is developed with input from statisticians, epidemiologists,
economists, political scientists, and policy analysts alike.
23
Acknowledgements
The authors thank Alyssa Bilinski for helpful comments on the draft. This work was
supported by funding from the Laura and John Arnold Foundation. The content is solely
the responsibility of the authors and does not necessarily represent the views of the Laura
and John Arnold Foundation.
References
Abadie, A. (2005), ‘Semiparametric difference-in-differences estimators’, Review of Eco-
nomic Studies 72, 1–19.
Angrist, J. D. & Pischke, J.-S. (2008), Mostly Harmless Econometrics: An Empiricist’s
Companion, Princeton University Press, Princeton, NJ.
URL: http://www.mostlyharmlesseconometrics.com/
Antonisse, L., Garfield, R., Rudowitz, R. & Artiga, S. (2018), The effects of medicaid
expansion under the aca: Updated findings from a literature review, Technical report,
Henry J Kaiser Family Foundation (KFF).
URL: https://www.kff.org/medicaid/issue-brief/the-effects-of-medicaid-expansion-
under-the-aca-updated-findings-from-a-literature-review-march-2018/
Bai, J. (2009), ‘Panel data models with interactive fixed effects’, Econometrica 77(4), 1229–
1279.
Bilinski, A. & Hatfield, L. A. (2018), ‘Seeking evidence of absence: Reconsidering tests of
model assumptions’, arXiv:1805.03273 [stat] . arXiv: 1805.03273.
URL: http://arxiv.org/abs/1805.03273
Blavin, F. (2016), ‘Association between the 2014 Medicaid expansion and us hospital fi-
nances’, JAMA 316, 1475–1483.
Bradford, A. C., Bradford, W. D., Abraham, A. & Bagwell Adams, G. (2018), ‘Association
between US state medical cannabis laws and opioid prescribing in the Medicare Part D
24
population’, JAMA Internal Medicine 178(5), 667.
URL: http://archinte.jamanetwork.com/article.aspx?doi=10.1001/jamainternmed.2018.0266
Card, D. & Krueger, A. B. (1993), Minimum wages and employment: A case study of the
fast food industry in new jersey and pennsylvania, Working Paper 4509, National Bureau
of Economic Research.
URL: http://www.nber.org/papers/w4509
Daw, J. R. & Hatfield, L. A. (2018), ‘Matching and regression-to-the-mean in difference-
in-differences analysis’, Health Services Research .
Desai, S., Hatfield, L. A., Hicks, A. L., Chernew, M. E. & Mehrotra, A. (2016), ‘Associa-
tion between availability of a price transparency tool and outpatient spending’, JAMA
315, 1874–81.
Ding, P. & Li, F. (2019), ‘A bracketing relationship between difference-in-differences and
lagged-dependent-variable adjustment’, arXiv preprint arXiv:1903.06286 .
Graham, N., Arai, M. & Hagstro¨mer, B. (2016), ‘multiwayvcov: Multi-way standard error
clustering. r package version 1.2. 3’.
Han, B., Yu, H. & Friedberg, M. W. (2017), ‘Evaluating the impact of parent-reported
medical home status on children’s health care utilization, expenditures, and quality: a
difference-in-differences analysis with causal inference methods’, Health Serv Res 52, 786–
806.
Hernan, M. A. & Robins, J. M. (2019), Causal inference, CRC Boca Raton, FL.
URL: https://www.hsph.harvard.edu/miguel-hernan/causal-inference-book/
Ho, D. E., Imai, K., King, G. & Stuart, E. A. (2011), ‘MatchIt: Nonparametric prepro-
cessing for parametric causal inference’, Journal of Statistical Software 42(8), 1–28.
URL: http://www.jstatsoft.org/v42/i08/
Kahn-Lang, A. & Lang, K. (2018), The promise and pitfalls of differences-in-differences:
reflections on 16 and Pregnant and other applications, Technical Report 24857, National
25
Bureau of Economic Research, Cambridge, MA.
URL: http://www.nber.org/papers/w24857
Karaca-Mandic, P., Norton, E. C. & Dowd, B. (2012), ‘Interaction terms in nonlinear
models’, Health Services Research 47(1pt1), 255–274.
URL: http://doi.wiley.com/10.1111/j.1475-6773.2011.01314.x
Keele, L. J., Small, D. S., Hsu, J. Y. & Fogarty, C. B. (2019), ‘Patterns of effects and
sensitivity analysis for differences-in-differences’, arXiv preprint arXiv:1901.01869 .
Kobayashi, L. C., Altindag, O., Truskinovsky, Y. & Berkman, L. F. (2019), ‘Effects of the
affordable care act medicaid expansion on subjective well-being in the us adult popula-
tion, 2010–2016’, American journal of public health 109(9), 1236–1242.
Lechner, M. (2011), ‘The estimation of causal effects by difference-in-difference methods’,
Foundations and Trends® in Econometrics 4(3), 165–224.
Lindner, S. & McConnell, K. J. (2018), ‘Difference-in-differences and matching on out-
comes: a tale of two unobservables’, Health Services and Outcomes Research Methodology
.
URL: http://link.springer.com/10.1007/s10742-018-0189-0
McWilliams, J. M., Landon, B. E., Chernew, M. E. & Zaslavsky, A. M. (2014), ‘Changes
in patients’ experiences in Medicare accountable care organizations’, The New England
journal of medicine 371, 1715–24.
National Federation of Independent Business v. Sebelius (2011), www.oyez.org/cases/
2011/11-393. Accessed: 2019-07-18.
O’Neill, S., Kreif, N., Grieve, R., Sutton, M. & Sekhon, J. S. (2016), ‘Estimating causal
effects: considering three alternatives to difference-in-differences estimation’, Health Serv
Outcomes Res Methodol 16, 1–21.
26
R Core Team (2019), R: A Language and Environment for Statistical Computing, R Foun-
dation for Statistical Computing, Vienna, Austria.
URL: https://www.R-project.org/
Roberts, E. T., McWilliams, J. M., Hatfield, L. A., Gerovich, S., Chernew, M. E.,
Gilstrap, L. G. & Mehrotra, A. (2018), ‘Changes in health care use associated with
the introduction of hospital global budgets in maryland’, JAMA Internal Medicine
178(2), 260.
URL: http://archinte.jamanetwork.com/article.aspx?doi=10.1001/jamainternmed.2017.7455
Rosenbaum, P. R. (1984), ‘The consequences of adjustment for a concomitant variable that
has been affected by the treatment’, Journal of the Royal Statistical Society: Series A
(General) 147(5), 656–666.
Rosenthal, M. B., Landrum, M. B., Robbins, J. A. & Schneider, E. C. (2016), ‘Pay for
performance in Medicaid: Evidence from three natural experiments’, Health Services
Research 51, 1444–66.
Ryan, A. M., Burgess, J. F. & Dimick, J. B. (2015), ‘Why we should not be indifferent to
specification choices for difference-in-differences’, Health Services Research .
Stuart, E. A., Huskamp, H. A., Duckworth, K., Simmons, J., Song, Z., Chernew, M. E. &
Barry, C. L. (2014), ‘Using propensity scores in difference-in-differences models to esti-
mate the effects of a policy change’, Health Services and Outcomes Research Methodology
14(4), 166–182.
VanderWeele, T. J. & Shpitser, I. (2013), ‘On the definition of a confounder’, The Annals
of Statistics 41(1), 196–220.
URL: http://projecteuclid.org/euclid.aos/1364302740
Xu, Y. (2017), ‘Generalized synthetic control method: Causal inference with interactive
fixed effects models’, Political Analysis 25(1), 57–76.
27
Appendix A - Adjusting for Time-Varying Covariates
In this section of the appendix, we discuss of the problems of adjusting for time-varying
confounders as described in Section 3.2 in the main paper. The thesis of our argument is
that a time-varying covariate that is *affected* by treatment and also affects the outcome
makes recovering the causal effect difficult. On one hand, failing to adjust for the time-
varying covariate will result in failures of parallel trends. On the other hand, adjusting for
the time-varying covariate, since it is on the pathway between treatment and the outcome,
will negate some of the effect of treatment on the outcome, resulting in biased estimates.
We begin with notation that should be familiar to those who read our paper. Y (t)
is the continuous outcome measured at time t. For simplicity, we assume that t ∈ {0, 1}
where t = 0 is the pre-treatment period and t = 1 the post-treatment period. Treatment is
binary and represented by A. Finally, we have a time-varying covariate Xit where i in an
index for a unit (e.g., a state or an individual). Let τat = E[Xit | A = a] be the covariate
group-time mean. We also introduce counterfactual notation for the covariate so that Xait is
the (possibly counterfactual) value of X for individual i and time t under treatment A = a.
Since we assume that treatment directly affects X, we may have that X0i1 6= X1i1.
Let’s extend the notation for the covariate means to counterfactual world so that E(X0it |
A = a) = τ 0at and E(X
1
it | A = a) = τ 1at. We assume that treatment (which occurs between
times 0 and 1) does not affect past versions of X so that τ 0a0 = τ
1
a0 = τa0. We also assume
that the covariate evolves differently in the two groups even absent treatment, leading to
the failure of parallel trends. That is, τ01 − τ00 6= τ11 − τ10.
Suppose we have the same model for untreated outcomes as the main text:
E
[
Y 0i (t)|A = ai, X0 = x0it
]
= α0 + α1ai + ζt + λtx
0
it.
For simplicity, let λt = λ. We can connect the untreated outcomes to the treated outcomes
with a fixed treatment effect, γ: Y 1i (t) = Y
0
i (t) + γ .
Recall that the average treatment effect on the treated (ATT) is
ATT = E
{
Y 1(1)− Y 0(1) | A = 1} .
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Now, we have:
E
{
Y 1(1) | A = 1} = α0 + α1 + ζ1 + λ1τ 111 + γ
and
E
{
Y 0(1) | A = 1} = α0 + α1 + ζ1 + λ1τ 011.
Plugging into the ATT:
ATT = λ1τ
1
11 + γ − λ1τ 011 = γ + λ1(τ 111 − τ 011).
The ATT is what we want to calculate, but what is our estimate for an unadjusted
model versus one from a regression model that correctly adjusts for X.
Unadjusted Estimator:
ˆATT unadj = {E (Y (1) | A = 1)− E (Y (0) | A = 1)} − {E (Y (1) | A = 0)− E (Y (0) | A = 0)}
= {α0 + α1 + ζ1 + λ1τ11 + γ − (α0 + α1 + ζ0 + λ0τ10)}−
{α0 + ζ1 + λ1τ01 − (α0 + ζ0 + λ0τ00)}
= γ + ζ1 − ζ0 + λ1τ11 − λ0τ10 − (ζ1 − ζ0 + λ1τ01 − λ0τ00)
= γ + λ1τ11 − λ0τ10 − λ1τ01 + λ0τ00
= γ + λ1(τ11 − τ01)− λ0(τ10 − τ00).
Without significant restrictions on the λ and τ values, this does not equal the ATT.
Adjusted Estimator:
Now, imagine we know which regression model to fit. In R, we can fit the model lm(y~a*t + x*t),
which is correctly specified. The estimate of the treatment effect will be the coefficient on
the interaction between a (treatment indicator) and t (time). However, when we fit the
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model, we will get:
ˆATT adj = γ,
which is biased for the true ATT.
Appendix B - Calculation of ATT for Simulation Sce-
nario 6
In the main paper, we state that the average treatment effect on the treated (ATT) in
Scenario 6 is different than in the other scenarios. Here, we show our calculations for the
ATT using our data-generating example. Below is the code used to generate data, using
the dplyr R package.
dat <- expand.grid(id = 1:n, tp = 1:max.time) %>%
arrange(id,tp) %>% group_by(id) %>%
mutate(int=rnorm(1,0,sd=0.25), # random intercept
p.trt=0.5, # probability of treatment
trt=rbinom(1, 1, p.trt), # treatment
x=rnorm(1, mean = 1.5 - 0.5*trt, sd = 1.5 - 0.5*trt),
post=I(tp >= trt.time), # indicator of post-treatment period
treated=I(post == 1 & trt == 1), # treated indicator
x=ifelse(tp>=2, lag(x, 1) + (tp-1)/10 *
rnorm(1, mean = 1, sd = 0.1) -
I(trt == 1) * I(tp>6)*(tp)/20, x)
) %>%
ungroup()
dat <- dat %>% mutate(err=rnorm(n*max.time),
y = 1 + x + trt + int + err + treated +
((tp - 2.5)^2)/10,
y.t = 1 + x * tp / 10 + trt +
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int + err + treated + ((tp - 2.5)^2)/10) %>%
group_by(id) %>%
mutate(y.diff = y - lag(y), y.diff2 = y.t - lag(y.t)) %>%
ungroup()
To begin, we only need to look at the treated group since the ATT is defined on the
treated population. The setup is relatively simple. We set n = 1000 to be the total number
of units followed over 10 (max.time) time points. Units were assigned to the treatment
group with probability 0.5. The treated units were given treatment beginning at t = 6;
thus, we had five pre-treatment time points and five post-treatment time points. The
covariate X at baseline was drawn from a Normal distribution, N(1, 12) from the treated
population. During the pre-treatment period, the means of the covariate increased by
about 1
10
cumulatively from t = 2, . . . , 10. However, the mean of the covariate was affected
by treatment too, so that for the treated group when t ≥ 6, the mean went down by an
average of 1
20
per time point.
Time t = 1 t = 2 t = 3 t = 4 t = 5 t = 6 t = 7 t = 8 t = 9 t = 10
Mean(X0) 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9
Mean(X1) 1.0 1.1 1.2 1.3 1.4 1.45 1.5 1.55 1.6 1.65
Table B1: Evolution of counterfactual means of covariate X for the treated group.
Note that for this simulation scenario, we have two different outcomes. In the first,
denoted y, the effect of X on the outcome is the same at every time point. For the second
outcome, denoted y.t, the covariate has a time-varying effect on the outcome. The two
outcome processes are detailed below:
y = 1 + x+ trt+ int+ err + treated+ ((tp− 2.5)2)/10
y.t = 1 + x ∗ tp/10 + trt+ int+ err + treated+ ((tp− 2.5)2)/10).
So this difference is that in the second equation, X interacts with time. Note that both
int and err are mean zero normal random variables and treated = 1 whenever tp > 5. (We
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are only considering the treated group. This would not be true for the comparison group.)
Like we did for the mean of X, we can build a table for the means of Y using the above
equations.
For y, we get the following results:
Time t = 1 t = 2 t = 3 t = 4 t = 5 t = 6 t = 7 t = 8 t = 9 t = 10 Avg. pre Avg. post
Mean(Y 0) 3.225 3.125 3.225 3.525 4.025 4.725 5.625 6.725 8.025 9.525 3.425 6.925
Mean(Y 1) 3.225 3.125 3.225 3.525 4.025 5.675 6.525 7.575 8.825 10.275 3.425 7.775
Table B2: Evolution of counterfactual means of outcome Y for the treated group.
We’ll calculate a few of these by hand to give an idea of what we’re doing. Take the
mean of Y 0 at t = 7:
y = 1 + x+ trt+ int+ err + treated+ ((tp− 2.5)2)/10
= 1 + x+ 1 + 0 + 0 + 0 + (7− 2.5)2/10
= 1 + 1.6 + 1 + 0 + 0 + 0 + (7− 2.5)2/10
= 5.625.
Here, we plugged in 1.6 for x since it equals the untreated mean of the covariate (see Table
B1). Both int and err are independent mean zero random variables so we plug in 0.
Following similar calculations, the mean of Y 1 at t = 7 is:
y = 1 + x+ trt+ int+ err + treated+ ((tp− 2.5)2)/10
= 1 + x+ 1 + 0 + 0 + 1 + (7− 2.5)2/10
= 1 + 1.5 + 1 + 0 + 0 + 1 + (7− 2.5)2/10
= 6.525.
The ATT here is 7.775 − 6.925 = 0.85, which is calculated by taking the mean of the
last 5 columns (the post-treatment time points) for each row and subtracting them.
And for y.t, we get the following results:
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Time t = 1 t = 2 t = 3 t = 4 t = 5 t = 6 t = 7 t = 8 t = 9 t = 10 Avg. pre Avg. post
Mean(Y 0) 2.325 2.245 2.385 2.745 3.325 4.125 5.145 6.385 7.845 9.525 2.605 6.605
Mean(Y 1) 2.325 2.245 2.385 2.745 3.325 5.095 6.075 7.265 8.665 10.275 2.605 7.475
Table B3: Evolution of counterfactual means of outcome Y for the treated group.
The ATT here equals 0.87.
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